Tevogen Bio Holdings Inc. (TVGN) Market Cap
Tevogen Bio Holdings Inc. has a market capitalization of $33.9M.
Financials based on reported quarter end 2025-12-31
Price: $8.14
▼ -0.51 (-5.90%)
Market Cap: 33.90M
NASDAQ · time unavailable
CEO: Ryan H. Saadi
Sector: Healthcare
Industry: Biotechnology
IPO Date: 2022-01-05
Website: https://tevogen.com
Tevogen Bio Holdings Inc. (TVGN) - Company Information
Market Cap: 33.90M · Sector: Healthcare
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Analyst Sentiment
50%
Hold
Based on 1 ratings
Consensus Price Target
No data available
Price & Moving Averages
Loading chart...
Related Companies in Healthcare
Fundamentals Overview
Loading fundamentals overview...
Loading financial data and tables...
📁